FR 2021-00285

The document reviewed is a notice from the Centers for Disease Control and Prevention (CDC), as published in the Federal Register. This notice communicates that a meeting is scheduled but will be closed to the public. This document, while not accompanied by an abstract, outlines important administrative procedures and delegation of authority within the CDC.

General Summary

The notice indicates that Kalwant Smagh, who serves as the Director of the Strategic Business Initiatives Unit at the CDC, has been delegated the authority to sign Federal Register notices that pertain to announcements of meetings and other management activities. This authority extends to both the CDC and the Agency for Toxic Substances and Disease Registry. For those seeking more information, Marilyn Ridenour is listed as a point of contact, offering her details for further inquiries.

Significant Issues and Concerns

In reviewing the document, several issues arise:

1. Lack of Abstract: The absence of an abstract limits a reader's initial understanding of the document’s intent. Typically, an abstract provides a concise summary, allowing readers to quickly ascertain the purpose and scope of the notice.

2. Ambiguity Around the Meeting: The document does not specify the nature or purpose of the meeting, nor does it explain why the meeting is closed to the public. This lack of detail may lead to questions around transparency and the necessity for confidentiality.

3. Complex Language: The language used, particularly around the delegation of authority, might be complex for individuals unfamiliar with governmental structures. This could obscure the understanding of what authority has been delegated and to whom.

4. Multiple Titles and Abbreviations: Marilyn Ridenour's titles and credentials are presented in a way that might be overwhelming or confusing for readers, especially those not familiar with such designations. Simplifying could aid in understanding her qualifications and role.

Impact on the Public

From a broad perspective, the document's implications for the public are limited in immediate, tangible impact due to its administrative nature. However, how these meetings and their proceedings reflect decision-making processes could have significant implications for public health policies and initiatives.

Impact on Specific Stakeholders

The document may have specific implications for stakeholders directly involved with or regulated by the CDC and the Agency for Toxic Substances and Disease Registry. These stakeholders could include public health officials, healthcare providers, environmental health experts, and possibly industries involved with toxic substances. The closed nature of the meeting might be viewed negatively, as it could foster concern about lack of transparency in decision-making processes affecting public health and safety.

In conclusion, while the document fulfills an administrative function, the lack of clarity on the specifics of the closed meeting raises questions of transparency. Efforts to simplify the language and offer context would benefit readers and enhance understanding and trust amongst the public and stakeholders alike.